Exane Derivatives’s Acceleron Pharma XLRN Stock Holding History

Exane Derivatives’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13	Closed	-$2.24K	–	1121
2021 Q3	$2.24K	Hold	13	–	–	﹤0.01%	797
2021 Q2	$1.51K	Hold	13	–	–	﹤0.01%	837
2021 Q1	$1.76K	Hold	13	–	–	﹤0.01%	690
2020 Q4	$1.66K	Sell	13 -967	-99%	-$113K	﹤0.01%	641
2020 Q3	$110K	Buy	+980	New	+$97.6K	0.03%	291

Exane Derivatives's XLRN Position: Q4 2021 in Review

Exane Derivatives sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 13 shares — an estimated $2.24K sold.

Exane Derivatives first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $110K in Q3 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Exane Derivatives reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 13 Acceleron Pharma shares in Q4 2021, an estimated $2.24K.
Exane Derivatives first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
Exane Derivatives's Acceleron Pharma position peaked at $110K in Q3 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.